Evidence map›Paper›PMID 38572567›Full record

ArticleHaematologica2024

Outcomes after chimeric antigen receptor T-cell therapy across large B-cell lymphoma subtypes.

Christianne Bourlon, Claire Roddie, Tobias Menne, Jane Norman, Maeve O'Reilly, Adam Gibb, Caroline Besley, Sridhar Chaganti, Carlos Gonzalez Arias, Ceri Jones and 13 more

Abstract readLetter
PubMed Full text at PMC Publisher
In one paragraph

Article in Haematologica, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

23 authors.

Christianne BourlonDepartment of Haematology, King's College Hospital, London.
Claire RoddieDepartment of Haematology, University College London Hospitals, London, UK; UCL Cancer Institute, University College London, London.
Tobias MenneDepartment of Haematology, Freeman Hospital, Newcastle University, Newcastle.
Jane NormanDepartment of Haematology, Manchester Royal Infirmary, Manchester.
Maeve O'ReillyDepartment of Haematology, University College London Hospitals, London.
Adam GibbDepartment of Medical Oncology, The Christie Hospital, Manchester.
Caroline BesleyDepartment of Haematology, University Hospitals Bristol and Weston, Bristol.
Sridhar ChagantiDepartment of Haematology, Queen Elizabeth Hospital, Birmingham.
Carlos Gonzalez AriasDepartment of Haematology, Royal Marsden Hospital, London.
Ceri JonesDepartment of Haematology. University Hospital of Wales, Cardiff.
Abdalla DikairDepartment of Haematology, Queen Elizabeth Hospital, Glasgow.
Sharon AllenDepartment of Haematology, Cambridge University Hospitals, Cambridge.
Frances SeymourDepartment of Haematology, Leeds Teaching Hospitals, Leeds.
Wendy OsborneDepartment of Haematology, Freeman Hospital, Newcastle University, Newcastle.
Amrith MathewDepartment of Haematology, Queen Elizabeth Hospital, Birmingham.
William TownsendDepartment of Haematology, University College London Hospitals, London.
Piers E M PattenDepartment of Haematology, King's College Hospital, London, UK; Comprehensive Cancer Centre, King's College London, London.
Eleni ThoulouliDepartment of Haematology, Manchester Royal Infirmary, Manchester.
Ahmed AbdulgawadDepartment of Haematology, The Christie Hospital, Manchester.
Sanne LugthartDepartment of Haematology, University Hospitals Bristol and Weston, Bristol.
Robin SandersonDepartment of Haematology, King's College Hospital, London.
Amy A KirkwoodCR UK and UCL Cancer Trials Centre, UCL Cancer Institute, UCL, London.
Andrea KuhnlDepartment of Haematology, King's College Hospital, London. andrea.kuhnl@nhs.net.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Immunotherapy, AdoptiveLymphoma, Large B-Cell, DiffuseReceptors, Chimeric AntigenFemaleHumansMaleTreatment OutcomeReceptors, Chimeric Antigen

Identifiers

PMID38572567
PMCPMC11290504

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.